InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INM · as of Jun 9, 2026
Key Statistics
Explore InMed Pharmaceuticals Inc. Data
inm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
inm competitorsINM
BDRX
BIVI
CNSP
ESLA
GLMDStock Performance
Full HistoryAbout InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary…
what is inmed pharmaceuticals inc. · inm stock overview · inmed pharmaceuticals inc. company profile · who is inmed pharmaceuticals inc. ceo · inm NASDAQ · inmed pharmaceuticals inc. headquarters · inmed pharmaceuticals inc. business segments
About Stock Overview & Key Data
InMed Pharmaceuticals Inc. (INM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 5, 2014. As of the latest trading session, INM stock price is $1.54, with a market capitalization of $2.8M. The stock has returned -45.96% over the past 12 months and +45.28% year-to-date.
According to 2 Wall Street analysts, the consensus rating for InMed Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, InMed Pharmaceuticals Inc. reported revenue of $4.9M and net income of -$8.2M. For detailed data — including InMed Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InMed Pharmaceuticals Inc. (INM) stock price is $1.54. The stock is traded on NASDAQ under the ticker symbol INM. The 52-week range is $0.57 – $5.50.